MVM
Medicxi Ventures Management Portfolio holdings
AUM
$427M
This Quarter Return
-6.61%
1 Year Return
+42.94%
3 Year Return
+262.94%
5 Year Return
+109.92%
10 Year Return
–
AUM
$172M
AUM Growth
+$172M
(-18%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Phathom Pharmaceuticals
PHAT
$864M
| $68.7M | 39.92% | 2,067,861 | – | – |
|
2
Vaxcyte
PCVX
$4B
| $50.2M | 29.15% | 1,887,478 | – | – |
|
3
Merus
MRUS
$4.98B
| $28M | 16.3% | 1,600,000 | – | – |
|
|
CMPI
4
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
| $21.9M | 12.73% | 1,501,716 | – | – |
|
|
OBSV
5
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $3.27M | 1.9% | 1,570,000 | – | – |
|